Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Faron Pharmaceuticals Ltd
Street 1: Joukahaisenkatu 6
Street 2:
City: Turku
Province: Province of Turku and Pori
Post Code: FI-20520
Country: Finland
Phone: +35824695151
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Juho
Last Name: Jalkanen
Title: Chief Development Officer

Alternate Focal Point Contact Information

Salutation: Mrs
First Name: Jenni
Last Name: Hurme
Title: HR Manager

General Information

Board Constituency: None
Is your organization legally registered in your country: Yes
If yes, please enter your registration number: 2068285-4
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
We are a clinical-stage biopharmaceutical company focusing on immuno-oncology, organ trauma and vascular damage. Since 2007 our goal has been to develop unique scientific discoveries into ground-breaking new treatments for hard-to-treat and rare diseases. To save lives.
We have an interest in continuing to develop our assets into more hard to treat indications, TB is one of these.
We are planning to bring the first immunotherapy to TB and rather than control TB, eradicate it.
Do you know about the UNHLM declaration: No

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Internet search
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
We are currently in discussions with Finland's national TB programme to eradicate both active and latent TB

Geographical Reach

Which country is your headquarters located in: Finland
Which countries do you do operate in:
(This includes countries you are conducting activities in)


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Developing Drugs for MDR and XDR

New TB Drugs:
As above

New TB Vaccines:
Immunotherapy to enhance the effectiveness of TB Vaccines

Basic research to support the mechanism of TB resistance and immune evasion


Declaration of interests:
We are biotech and aim to monetise our drugs however I do not see this as conflict but would like to disclose this

Application date: July 7, 2020
Last updated: July 7, 2020